...
首页> 外文期刊>Technology in cancer research & treatment. >Radiobiological Evaluation of Breast Cancer Radiotherapy Accounting for the Effects of Patient Positioning and Breathing in Dose Delivery. A Meta Analysis
【24h】

Radiobiological Evaluation of Breast Cancer Radiotherapy Accounting for the Effects of Patient Positioning and Breathing in Dose Delivery. A Meta Analysis

机译:乳腺癌放疗的放射生物学评估,考虑了患者在剂量输送中的位置和呼吸的影响。元分析

获取原文
           

摘要

In breast cancer radiotherapy, significant discrepancies in dose delivery can contribute to underdosage of the tumor or overdosage of normal tissue, which is potentially related to a reduction of local tumor control and an increase of side effects. To study the impact of these factors in breast cancer radiotherapy, a meta analysis of the clinical data reported by Mavroidis et al. (2002) in Acta Oncol (41:471–85), showing the patient setup and breathing uncertainties characterizing three different irradiation techniques, were employed. The uncertainties in dose delivery are simulated based on fifteen breast cancer patients (5 mastectomized, 5 resected with negative node involvement (R-) and 5 resected with positive node involvement (R+)), who were treated by three different irradiation techniques, respectively. The positioning and breathing effects were taken into consideration in the determination of the real dose distributions delivered to the CTV and lung in each patient. The combined frequency distributions of the positioning and breathing distributions were obtained by convolution. For each patient the effectiveness of the dose distribution applied is calculated by the Poisson and relative seriality models and a set of parameters that describe the dose-response relations of the target and lung. The three representative radiation techniques are compared based on radiobiological measures by using the complication-free tumor control probability, P + and the biologically effective uniform dose, D? concepts. For the Mastectomy case, the average P + values of the planned and delivered dose distributions are 93.8% for a D?CTV of 51.8 Gy and 85.0% for a D?CTV of 50.3 Gy, respectively. The respective total control probabilities, P B values are 94.8% and 92.5%, whereas the corresponding total complication probabilities, P I values are 0.9% and 7.4%. For the R- case, the average P + values are 89.4% for a D?CTV of 48.9 Gy and 88.6% for a D?CTV of 49.0 Gy, respectively. The respective P B values are 89.8% and 89.9%, whereas the corresponding P I values are 0.4% and 1.2%. For the R+ case, the average P + values are 86.1% for a D?CTV of 49.2 Gy and 85.5% for a D?CTV of 49.1 Gy, respectively. The respective P B values are 90.2% and 90.1%, whereas the corresponding P I values are 4.1% and 4.6%. The combined effects of positioning uncertainties and breathing can introduce a significant deviation between the planned and delivered dose distributions in lung in breast cancer radiotherapy. The positioning and breathing uncertainties do not affect much the dose distribution to the CTV. The simulated delivered dose distributions show larger lung complication probabilities than the treatment plans. This means that in clinical practice the true expected complications are underestimated. Radiation pneumonitis of Grade 1–2 is more frequent and any radiotherapy optimization should use this as a more clinically relevant endpoint.
机译:在乳腺癌放射治疗中,剂量传递的显着差异可能导致肿瘤剂量不足或正常组织剂量过多,这可能与减少局部肿瘤控制和增加副作用有关。为了研究这些因素对乳腺癌放疗的影响,对Mavroidis等人报道的临床数据进行了荟萃分析。 (2002年)在Acta Oncol(41:471–85)中,显示了表征三种不同辐照技术的患者设置和呼吸不确定性。剂量传递的不确定性是根据分别接受三种不同辐照技术治疗的15例乳腺癌患者(5例经直肠切除术,5例淋巴结受累切除(R-)和5例淋巴结受累切除(R +))模拟的。在确定每个患者输送到CTV和肺部的实际剂量分布时,要考虑到定位和呼吸效果。通过卷积获得定位和呼吸分布的组合频率分布。对于每个患者,所应用的剂量分布的有效性由泊松模型和相对序列模型以及一组描述靶标和肺部的剂量反应关系的参数计算得出。使用无并发症的肿瘤控制概率P +和生物学有效的统一剂量D +,根据放射生物学方法对三种代表性的放射技术进行了比较。概念。对于乳房切除术病例,计划的和交付的剂量分布的平均P +值分别为:D?CTV为51.8 Gy的93.8%和D?CTV为50.3 Gy的85.0%。各自的总控制概率P B值为94.8%和92.5%,而相应的总并发症概率P I值为0.9%和7.4%。对于R-情况,D?CTV为48.9 Gy时,平均P +值分别为89.4%和D?CTV为49.0 Gy时为88.6%。各自的P B值是89.8%和89.9%,而相应的PI值是0.4%和1.2%。对于R +情况,D?CTV为49.2 Gy时,平均P +值分别为86.1%和D?CTV为49.1 Gy时为85.5%。各自的P B值为90.2%和90.1%,而相应的PI值为4.1%和4.6%。位置不确定性和呼吸的综合作用会在乳腺癌放射治疗中在肺部计划和已分发的剂量分布之间引入明显的偏差。定位和呼吸的不确定性不会对CTV的剂量分布产生太大影响。模拟的给药剂量分布显示出比治疗计划更大的肺部并发症概率。这意味着在临床实践中,实际预期的并发症被低估了。 1-2级放射性肺炎更为常见,任何放疗优化都应将此作为更临床相关的终点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号